![](/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBHQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--e623d2450603cd9d4e6c86eae39da2c5b7f7bdd9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdERG9MY21WemFYcGxTU0lOTXpJd2VERTRNRjRHT2daRlZEb0pZM0p2Y0VraUVETXlNSGd4T0RBck1Dc3dCanNHVkRvTVozSmhkbWwwZVVraUMyTmxiblJsY2dZN0JsUTZESEYxWVd4cGRIbHBWVG9LYzNSeWFYQlVPZzVwYm5SbGNteGhZMlZKSWdsTWFXNWxCanNHVkRvTFpHVm1hVzVsU1NJZWFuQmxaenBtWVc1amVTMTFjSE5oYlhCc2FXNW5QVzltWmdZN0JsUT0iLCJleHAiOm51bGwsInB1ciI6InZhcmlhdGlvbiJ9fQ==--daee5f4cd191d67586af9b48495fbde7d4763d64/lucas-vasques-453684-unsplash.jpg)
Search
Filter Results
Displaying 51–60 of 1000 results
-
Jun 7, 2024
Eye on the Cure Podcast | Episode 67: Dr. Peter Campochiaro
Dr. Peter Campochiaro, a clinician-scientist and the Eccles Professor of Ophthalmology and Neuroscience at the Johns Hopkins University School of Medicine, talks to host Ben Shaberman about N-acetylcysteine (NAC), a drug that shows promise for preserving cone vision (central vision and acuity) in people with retinitis pigmentosa. The powerful antioxidant has moved into a 30+ site, Phase 3 clinical trial called NAC Attack.
-
Jun 5, 2024
Antabuse Moves into Clinical Trial for People with RP
Researchers believe the FDA-approved drug can reduce the hyperactivity of ganglion cells to improve vision.
-
May 30, 2024
Recording Available: Foundation Insights Forum – May 23, 2024
The Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on May 23, 2024.
The guest speaker for this call included Rachelle Lin, OD, MS, FAAO, associate professor, Southern California College of Optometry at Marshall B. Ketchum University, where she teaches low vision rehabilitation and genetics.
-
-
May 24, 2024
Eye on the Cure Podcast | Episode 66: Peter Wallsten
Peter Wallsten, a veteran newspaper journalist and head of investigative reporting at The Washington Post, talks to host Ben Shaberman.
-
May 22, 2024
ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision
The emerging treatment is designed to work for people with RP and other conditions regardless of the gene mutation causing disease
-
May 22, 2024
Advancing Research Solutions for PRPH2-Associated Retinal Diseases.
-
Visionary Circle Spring 2024 Science & Research Webinar
Please join us for a special research update presentation to our extraordinary Visionary Circle partners.
-
Visionary Circle Spring 2024 Science & Research Webinar
Please join us for a special research update presentation to our extraordinary Visionary Circle partners.
-
May 20, 2024
Isaiah Bingham is the first legally blind football player in Delaware. At just 14 years old, he’s excelling as a team captain and award-winning athlete and is inspiring others as he advocates for those with disabilities.